Top Markets
Coin of the day
Photocure ASA Photocure ASA

Photocure ASA

PHO
Pozycja w akcjach #19788
Photocure ASA is a specialized pharmaceutical enterprise focused on the... Photocure ASA is a specialized pharmaceutical enterprise focused on the development, manufacturing, commercialization, and distribution of medicinal products. Its operational footprint extends across multiple European nations, including the Nordic region, Germany, France, Austria, the United Kingdom, the Netherlands, and Italy, in addition to the United States. The company's primary offering, Hexvix/Cysview, aids in the identification and ongoing management of bladder cancer. Moreover, Photocure is actively progressing Cevira, a therapeutic agent in development targeting human papilloma virus (HPV) infections and pre-cancerous lesions of the cervix. The firm distributes its products to pharmaceutical wholesalers, pharmacies, and healthcare institutions through collaborative licensing arrangements. Founded in 1993, Photocure ASA maintains its corporate headquarters in Oslo, Norway.
Cena akcji
$5.66
Ostatnia synchronizacja: 2026-08-25
Kapitalizacja rynkowa
$150.59M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
-7.22%
Kraj
NO
Handel Photocure ASA (PHO)

Kategoria

Historia stopy dywidendy dla Photocure ASA (PHO)
Stopa dywidendy (TTM) dla Photocure ASA (symbol akcji: PHO) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Photocure ASA (PHO) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji